Related Experiment Video
Updated: Feb 16, 2026

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Principal component analysis of coagulation assays in severely injured children
Christine M Leeper1, Matthew D Neal2, Christine McKenna3
1Division of General Surgery and Trauma, Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA; Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA.
Insights
Trauma-induced coagulopathy in children presents three distinct patterns: clot strength, fibrinolysis, and clotting factor depletion. Fibrinolysis abnormalities are linked to severe injury and worse outcomes, including VTE and disability.
Area of Science:
- Pediatric critical care
- Trauma surgery
- Hematology
Background:
- Trauma-induced coagulopathy is a frequent complication in pediatric trauma patients.
- Coagulopathy is associated with increased mortality and morbidity in injured children.
Purpose of the Study:
- To identify distinct patterns (phenotypes) of coagulation dysregulation in children following severe trauma.
- To associate these identified coagulation phenotypes with clinical outcomes such as mortality, disability, and need for blood transfusion.
Main Methods:
- Principal component analysis (PCA) was applied to prospectively collected data from pediatric trauma patients.
- Coagulation parameters including international normalized ratio, platelet count, and thromboelastography variables were analyzed.
- PCA identified key components representing coagulation patterns, which were then used in logistic regression to assess associations with clinical outcomes.
Main Results:
- Three significant principal components explained 75% of the variance in coagulation parameters.
- These components represented clot strength, abnormal fibrinolysis (hyperfibrinolysis or shutdown), and global clotting factor depletion.
- All three patterns were associated with increased mortality and blood transfusion requirements.
- Abnormal fibrinolysis was significantly correlated with injury severity and predicted venous thromboembolism and functional disability.
Conclusions:
- PCA effectively identifies three distinct patterns of coagulation dysregulation in pediatric trauma using standard laboratory tests.
- While clot strength and factor depletion are linked to adverse outcomes, abnormal fibrinolysis is particularly associated with severe injury and portends a worse prognosis, including higher risks of VTE and disability.
Background:
Trauma-induced coagulopathy is common and associated with poor outcome in injured children. Our aim is to identify patterns of coagulation dysregulation after injury and associate these phenotypes with relevant clinical outcomes.
Methods:
We performed principal components analysis on prospectively collected data from children with the highest-level trauma activation June 2015-June 2016. Parameters included admission international normalized ratio, platelet count and thromboelastograms. Variables were reduced to principal components; principal component scores were generated for each subject and used in logistic regression with outcomes including mortality, disability, venous thromboembolism, and blood transfusion in the first 24 hours.
Results:
We included 133 subjects with median interquartile range age =10 (5-13 years), median interquartile range Injury Severity Score =17 (9-25), 73.5% boys, 70.8% blunt trauma. principal component analysis identified 3 significant principal components accounting for 75.0% of overall variance. Principal component 1 reflected clot strength; principal component 2 reflected abnormal fibrinolysis, both hyperfibrinolysis and fibrinolysis shutdown; principal component 3 reflected global clotting factor depletion. High principal component 1 score was associated with increased mortality (odds ratio =1.63) and blood transfusion (odds ratio 1.36). Principal component 2 score was correlated with Injury Severity Score (rho 0.4) and associated with venous thromboembolism (odds ratio 1.84), functional disability (odds ratio 1.66), mortality (odds ratio 2.07) and blood transfusion (odds ratio 2.79). PC3 score was associated with increased mortality (odds ratio 1.92) and blood transfusion (odds ratio 1.25).
Conclusion:
Principal component analysis detects 3 patterns of coagulation dysregulation using widely available laboratory parameters: (1) abnormalities in clot strength; (2) abnormalities in fibrinolysis, and (3) clotting factor depletion. While all were associated with mortality and transfusion, fibrinolytic dysregulation was associated with injury severity and portends particularly poor outcome including venous thromboembolism and disability.
More Related Videos
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
13:08Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Related Concept Videos
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Coagulation
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Anticoagulant Drugs: Low-Molecular-Weight Heparins